This is in concordance with the work of Bellini et al. who performed deep sequence of exons 23 and 25 of ALK in a series of 276 NB samples and showed that more than half of the identified point mutations were subclonal events that might have gone undetected by Sanger sequencing. This evidence concerns the gene ALK and neuroblastoma.